Ajinomoto Bio-Pharma Services

61 articles with Ajinomoto Bio-Pharma Services

• GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center

  4/8/2019

  Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that GeneDesign, Inc. has joined the global organization.

• Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services' Global Leadership Team as Vice President of Sales and Marketing

  4/3/2019

  Ajinomoto Bio-Pharma Services, a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Jean-Baptiste Agnus has joined Aji Bio-Pharma as Vice President of Sales and Marketing.

• Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth

  3/12/2019

  Ajinomoto Bio-Pharma Services, a leading global provider of bio-pharmaceutical contract development and manufacturing provided an update on several of its capital projects currently underway in both the United States and Belgium.

• Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform

  12/18/2018

  Ajinomoto Bio-Pharma Services and XL-protein GmbH, are pleased to announce a Strategic Alliance.

• Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

  11/28/2018

  Ajinomoto Bio-Pharma Services presented data at the World ADC Summit in San Diego this month describing a proprietary site-selective bioconjugation technology, AJICAP™.

• Ajinomoto Althea, Inc. Celebrates 20 years in San Diego and the Opening of New Facility

  8/27/2018

  Ajinomoto Althea, Inc. celebrated its 20th year in operation, making it one of the true anchors of the San Diego life science community.

• Ajinomoto Althea, Inc. Announces Additions to Management Team as it transforms into a global CDMO

  5/31/2018

  Ajinomoto Althea, Inc. announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.

• Ajinomoto Althea Inc. Opens Manufacturing Suites In New High Potency And Antibody Drug Conjugate Commercial Facility

  9/19/2017

• Ajinomoto Althea Inc. Announces New Aseptic Fill Finish Line

  8/24/2017

• Ajinomoto Althea Inc. CEO David Enloe Awarded "Most Admired CEO"

  7/6/2017

• Biologics Candidate Manufactured Using Ajinomoto Althea Inc.'s CORYNEX Protein Expression System Enters Clinical Trials For The First Time

  10/4/2016

• Ajinomoto Althea Inc. Announces Issuance Of New US Patent For Manufacturing Of Crystal Monoclonal Antibodies

  5/17/2016

• Ajinomoto Althea Inc. Expands Its Capacity Of Fill Finish Manufacturing With Addition Of Second Shift

  3/15/2016

• Ajinomoto Althea Inc. Launches Process And Analytical Development Services For Antibody Drug Conjugates (ADCs) Therapeutics

  12/10/2015

• Ajinomoto Althea Inc. Receives European GMP Certification For Commercial Aseptic Filling And Testing

  6/16/2015

• Ajinomoto Completes Acquisition of Althea Technologies, Inc.

  4/5/2013

• Ajinomoto Agrees to Acquire Althea Technologies, Inc. for $175 Million

  3/6/2013

• Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production

  2/26/2013

• Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen

  10/24/2012

• Althea Technologies, Inc. Announces Expanded Roles for Key Executives

  9/24/2012